VSTM — Verastem Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in v… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$4.25
Market Cap$375M
Float70.4M
Shares Outstanding87.9M
Price/Sales (TTM)7.57
vs. Analyst Target+276.5% to analyst PT
Operating Margin (TTM)-240.46%
Revenue (TTM)$49.6M
Dividend RateNone
Analyst Target Price$16.00 (9 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $88.5M -$67.7M $54.8M -$50.5M
2021 $2.1M -$71.2M $2.1M -$61.2M
2022 $2.6M -$73.8M $2.6M -$71.6M
2023 N/A -$87.4M -$62,000 -$83.2M
2024 $10.0M -$131M $10.0M -$126M
2025 $30.9M -$209M $25.6M -$170M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $2.1M -$25.9M
Sep 2025 $11.2M -$98.5M
Dec 2025 $17.5M -$32.9M
Mar 2026 $18.7M -$36.6M

Ownership & Float

Insider Ownership0.7%
Institutional Ownership93.5%
Short Float24.9%
% of All Funds Holding1.67%
Number of Funds Holding137

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$5.20Near-term / short-term trend
Weekly40-Week SMA$7.29Medium-term trend
Weekly80-Week SMA$6.65Cyclical trend (business cycle)
Weekly200-Week SMA$7.12Secular trend (multi-year)
Monthly10-Month SMA$7.27Near-term monthly trend
Monthly20-Month SMA$6.50Medium-term monthly trend
Monthly40-Month SMA$6.92Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$4.20 support 1.67x 9 months ago
$3.90 support 1.54x 17 months ago

Historical Earnings Reactions (58 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.07% 0.00% 46.55% 12.58% -31.22%
1 Day 0.06% 0.00% 48.28% 19.93% -28.04%
1 Week 0.73% -0.10% 50.00% 46.26% -20.75%
2 Weeks 0.37% 0.85% 51.72% 61.57% -65.44%
1 Month 7.04% 2.86% 54.39% 91.67% -70.13%

Next earnings: May 7, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan7.5%57.1%14
Feb-0.7%40.0%15
Mar8.3%46.7%15
Apr-2.2%46.7%15
May8.4%50.0%14
Jun-4.5%35.7%14
Jul7.4%42.9%14
Aug1.4%35.7%14
Sep-7.3%28.6%14
Oct-10.2%28.6%14
Nov13.2%78.6%14
Dec-6.5%28.6%14

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.04% 43.9% 676
Tuesday 0.06% 45.1% 741
Wednesday 0.00% 44.9% 737
Thursday 0.14% 45.3% 724
Friday 0.16% 45.4% 723

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 93.5%

Insider Transactions — Smart Summary

Total insider ownership: 0.7%

12-Month Insider Activity Summary

Total Filings27
Net Value-$570,857.756
Net Shares Change-92,494
% of Float-0.1%
C-Suite Filings18
Clusters Detected4

Key Insiders

NameTitleNet ValueFilingsActivity
Paterson Dan President and CEO -$171,837.07 4 1 sell
Kauffman Michael -$85,500 1 N/A
Bunn Paul A. -$75,496.98 1 N/A
Calkins Daniel Chief Financial Officer -$57,281.453 2 N/A
Stuglik Brian M -$3,356.1 1 1 sell
Gagnon Robert E. -$1,604.6 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-06-20 – 2025-06-24 5 4 -$119,410.702 3 C-suite
2025-09-18 – 2025-09-24 4 4 -$13,315.727 2 C-suite
2025-11-25 – 2025-12-09 6 3 -$373,922.5 4 C-suite
2025-12-12 – 2025-12-18 4 3 -$51,729.52 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-06-20 Paterson Dan President and CEO -$1,892.75 Transaction at $5.65, now -24.8%
2025-06-20 Stuglik Brian M -$3,356.1 Transaction at $5.65, now -24.8%
2025-06-20 Gagnon Robert E. -$1,604.6 Transaction at $5.65, now -24.8%
2025-11-25 Kauffman Michael -$85,500 Transaction at $10.00, now -57.5%
2025-10-14 Bunn Paul A. -$75,496.98 Transaction at $9.06, now -53.1%
2026-01-14 Paterson Dan President and CEO -$73,898.36 Transaction at $7.16, now -40.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Verastem Inc (VSTM) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for VSTM on Trend Edge →